BioCryst Pharmaceuticals, Inc. (BCRX)
9.67
+0.12
(+1.26%)
USD |
NASDAQ |
Aug 24, 16:00
9.77
+0.10
(+1.03%)
After-Hours: 20:00
BioCryst Pharmaceuticals Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 30, 2020 | 39.37 |
| December 29, 2020 | 36.95 |
| December 28, 2020 | 37.69 |
| December 24, 2020 | 38.21 |
| December 23, 2020 | 39.66 |
| December 22, 2020 | 39.84 |
| December 21, 2020 | 43.57 |
| December 18, 2020 | 45.19 |
| December 17, 2020 | 43.04 |
| December 16, 2020 | 43.51 |
| December 15, 2020 | 43.62 |
| December 14, 2020 | 44.62 |
| December 11, 2020 | 42.62 |
| December 10, 2020 | 40.16 |
| December 09, 2020 | 38.11 |
| December 08, 2020 | 40.21 |
| December 07, 2020 | 37.90 |
| December 04, 2020 | 32.02 |
| December 03, 2020 | 26.95 |
| December 02, 2020 | 26.46 |
| December 01, 2020 | 25.56 |
| November 30, 2020 | 26.82 |
| November 27, 2020 | 26.93 |
| November 25, 2020 | 24.99 |
| November 24, 2020 | 24.46 |
| Date | Value |
|---|---|
| November 23, 2020 | 23.10 |
| November 20, 2020 | 22.73 |
| November 19, 2020 | 21.89 |
| November 18, 2020 | 22.47 |
| November 17, 2020 | 24.04 |
| November 16, 2020 | 23.36 |
| November 13, 2020 | 23.15 |
| November 12, 2020 | 22.31 |
| November 11, 2020 | 22.36 |
| November 10, 2020 | 21.42 |
| November 09, 2020 | 20.37 |
| November 06, 2020 | 21.42 |
| November 05, 2020 | 22.23 |
| November 04, 2020 | 22.41 |
| November 03, 2020 | 20.73 |
| November 02, 2020 | 20.18 |
| October 30, 2020 | 20.05 |
| October 29, 2020 | 19.58 |
| October 28, 2020 | 19.05 |
| October 27, 2020 | 19.47 |
| October 26, 2020 | 20.16 |
| October 23, 2020 | 19.47 |
| October 22, 2020 | 20.16 |
| October 21, 2020 | 18.84 |
| October 20, 2020 | 18.42 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen, Inc. | 20.53 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
| Agenus, Inc. | -- |
| Anika Therapeutics, Inc. | 2.077 |
| Imunon, Inc. | 1.787 |
Price to Book Value Related Metrics
| PS Ratio | 2.433 |
| PEG Ratio | -0.0084 |
| Price to Free Cash Flow | 6.424 |
| Price | 9.67 |
| Earnings Yield | -15.55% |
| Market Cap | 2.468B |
| PEGY Ratio | -0.0084 |
| Operating PE Ratio | 5.950 |
| Normalized PE Ratio | 17.32 |